Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 42, Issue 6, 2015, Pages 994-1001

  Minoia, Francesca ^a   Davì, Sergio ^a   Horne, Annacarin ^b   Bovis, Francesca ^a   Demirkaya, Erkan ^c   Akikusa, Jonathan ^d   Ayaz, Nuray A ^e   Al Mayouf, Sulaiman M ^f   Barone, Patrizia ^g   Bica, Bianca ^h   Bolt, Isabel ⁱ   Breda, Luciana ^j   De Cunto, Carmen ^k   Enciso, Sandra ^l   Gallizzi, Romina ^b   Griffin, Thomas ^c   Hennon, Teresa ^a   Horneff, Gerd ^a   Jeng, Michael ^m   Kapovic, Ageza M ⁿ   Lipton, Jeffrey M ^o   Manzoni, Silvia Magni ^p   Rozenfelde, Rumba Ingrida ^q   Magalhaes, Claudia Saad ^a   Sewairi, Wafaa M ^r   Stine, Kimo C ^s   Vougiouka, Olga ^t   Weaver, Lehn K ^u   Davidsone, Zane ^v   De Inocencio, Jaime ^w   Ioseliani, Maka ^x   Lattanzi, Bianca ^y   Tezer, Hasan ^z   Buoncompagni, Antonella ^aa   Picco, Paolo ^ab   Ruperto, Nicolino ^ac,ae   Martini, Alberto ^ad,af   Cron, Randy Q ^a,ag   Ravelli, Angelo ^a   more..

^a G GASLINI INSTITUTE   (Italy)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e Bakirkoy Maternity and Children Education Hospital   (Turkey)

^f KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^g UNIVERSITY OF CATANIA   (Italy)

^h FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j Ospedale Policlinico   (Italy)

^k HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^l HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^m UNIVERSITY OF MESSINA   (Italy)

ⁿ LEVINE CANCER INSTITUTE   (United States)

^o CHILDREN S HOSPITAL OF BUFFALO   (United States)

^p Zentrum fuer Allgemeine Paediatrie und Neonatologie   (Germany)

^q STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r Children's University Hospital Zagreb   (Croatia)

^s Steven and Alexandra Cohen Children's Medical Center of New York   (United States)

^t BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^u UNIVERSITY OF LATVIA   (Latvia)

^v Hospital das Clínicas HC   (Brazil)

^w KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^x ARKANSAS CHILDREN S HOSPITAL   (United States)

^y Department of Oral and Maxillofacial Surgery at A   (Greece)

^z CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^aa CHILDREN'S CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^ab HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^ac M Iashvili Children's Central Clinic   (Georgia)

^ad OSPEDALI RIUNITI   (Italy)

^ae GAZI UNIVERSITY   (Turkey)

^af UNIVERSITY OF GENOA   (Italy)

^ag UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMOPHAGOCYTIC SYNDROMES; MACROPHAGE ACTIVATION SYNDROME; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

Indexed keywords

CYCLOSPORIN; ETOPOSIDE; FIBRINOGEN; IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ERYTHROPHAGOCYTOSIS; GEOGRAPHIC DISTRIBUTION; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; NORTH AMERICA; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; THROMBOCYTE COUNT; AGE DISTRIBUTION; ARTHRITIS, JUVENILE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; FACTUAL DATABASE; FEMALE; INTERNATIONAL COOPERATION; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SEX RATIO; SURVIVAL ANALYSIS;

ADOLESCENT; AGE DISTRIBUTION; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; INTERNATIONALITY; MACROPHAGE ACTIVATION SYNDROME; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84939607119     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141261     Document Type: Article

References (28)

1. Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012;13:289-98.
2. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 2010;22:561-6.
3. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
4. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133-8.
5. Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:965-71.
6. Athreya BH. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002;20:121-3.
7. Ramanan AV, Schneider R. Macrophage activation syndrome-what's in a name! J Rheumatol 2003;30:2513-6.
8. Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther 2012;14:213.
9. Aricò M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996;10:197-203.
10. Ho C, Yao X, Tian L, Li FY, Podoltsev N, Xu ML. Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol 2014;141:62-71.
11. Zhang M, Behrens EM, Atkinson TP, Shakoory B, Grom AA, Cron RQ. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep 2014;16:439.
12. Sawhney S, Woo P, Murray K. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-6.
13. Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, et al ; Pediatric Rheumatology International Trials Organization; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014;66:3160-9.
14. Davì S, Lattanzi B, Demirkaya E, Rosina S, Bracciolini G, Novelli A, et al. Toward the development of new diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Paediatr Rheumatol 2012;1:1-7.
15. Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, et al; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2014;66:2871-80.
16. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al ; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
17. Laposata M. SI unit conversion guide. Boston: NEJM Books; 1992.
18. Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol 2008;4:615-20.
19. Durand M, Troyanov Y, Laflamme P, Gregoire G. Macrophage activation syndrome treated with anakinra. J Rheumatol 2010;37:879-80.
20. Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology 2011;50:417-9.
21. Kahn PJ, Cron RQ. Higher-dose anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol 2013;40:743-4.
22. Mannion ML, Cron RQ. Intensive care requirement, rather than degree of serum ferritin elevation, predicts mortality in macrophage activation syndrome. Pediatr Crit Care Med 2012;13:616.
23. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005;146:598-604.
24. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
25. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 1996;129:750-4.
26. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr 1996;128:275-8.
27. Henter JI, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
28. Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 2011;121:2264-77.